PMID- 33614866 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210223 IS - 2352-2895 (Print) IS - 2352-2895 (Electronic) IS - 2352-2895 (Linking) VI - 14 DP - 2021 May TI - Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors. PG - 100304 LID - 10.1016/j.ynstr.2021.100304 [doi] LID - 100304 AB - Biological mechanisms associated with response to trauma may impact risk for depression. One such mechanism is endocannabinoid signaling (eCB), a neuromodulatory system comprised of the CB1 subtype of cannabinoid receptors (CB1R), encoded by the CNR1 gene, and two primary endogenous ligands: 2-arachidonoylglycerol (2-AG) and N-arachidonylethanolamine (AEA), hydrolyzed by monoacylglycerol lipase (gene name MGLL) and fatty acid amide hydrolase (gene name FAAH). Preclinical data suggest that eCB/CB1R signaling acts as a stress buffer and its loss or suppression increases depression-like behaviors. We examined circulating concentrations of the eCBs (2-AG and AEA) days and six months after a traumatic injury as a marker of eCB/CB1R signaling and as predictors of Center for Epidemiologic Studies of Depression Scale-Revised [CESD-R] scores as a measure of depression severity six months after injury. We also explored associations of CNR1, FAAH, and MGLL genetic variance with depression severity at six months. Results from hierarchical multiple linear regressions showed that higher 2-AG serum concentrations after trauma predicted greater depression at six months (beta = 0.23, p = 0.007); neither AEA after trauma, nor 2-AG and AEA at six months were significant predictors (p's > 0.305). Carriers of minor allele for the putative single nucleotide polymorphism in the CNR1 gene rs806371 (beta = 0.19, p = 0.024) experienced greater depression at six months. These data suggest that the eCB signaling system is highly activated following trauma and that eCB/CB1R activity contributes to long-term depression risk. CI - (c) 2021 The Authors. FAU - Fitzgerald, Jacklynn M AU - Fitzgerald JM AD - Marquette University, Department of Psychology, Milwaukee, WI, USA. FAU - Chesney, Samantha A AU - Chesney SA AD - Froedtert Memorial Lutheran Hospital - Neurological Rehabilitation Services, Milwaukee, WI, USA. FAU - Lee, Tara Sander AU - Lee TS AD - Charlotte Lozier Institute, Arlington, VA, USA. FAU - Brasel, Karen AU - Brasel K AD - Oregon Health & Science University, Portland, OR, USA. FAU - Larson, Christine L AU - Larson CL AD - University of Wisconsin - Milwaukee, Department of Psychology, Milwaukee, WI, USA. FAU - Hillard, Cecilia J AU - Hillard CJ AD - Medical College of Wisconsin, Neuroscience Research Center and Department of Pharmacology and Toxicology, Milwaukee, WI, USA. FAU - deRoon-Cassini, Terri A AU - deRoon-Cassini TA AD - Medical College of Wisconsin, Department of Surgery, Division of Trauma & Acute Care Surgery, Milwaukee, WI, USA. LA - eng PT - Journal Article DEP - 20210204 PL - United States TA - Neurobiol Stress JT - Neurobiology of stress JID - 101643409 PMC - PMC7876629 OTO - NOTNLM OT - Depression OT - Endocannabinoids OT - Genotype OT - Injuries OT - Trauma COIS- This work was supported by the National Institute of Mental Health (NIMH R21 MH102838; deRoon-Cassini, Hillard). This funding source had no direct involvement in the design, collection, analysis, and writing of this report. Drs. Fitzgerald, Chesney, Brasel, and Larson have no financial disclosures to report and no authors have any conflicts of interest to report. EDAT- 2021/02/23 06:00 MHDA- 2021/02/23 06:01 PMCR- 2021/02/04 CRDT- 2021/02/22 05:58 PHST- 2020/08/17 00:00 [received] PHST- 2021/01/19 00:00 [revised] PHST- 2021/01/30 00:00 [accepted] PHST- 2021/02/22 05:58 [entrez] PHST- 2021/02/23 06:00 [pubmed] PHST- 2021/02/23 06:01 [medline] PHST- 2021/02/04 00:00 [pmc-release] AID - S2352-2895(21)00012-6 [pii] AID - 100304 [pii] AID - 10.1016/j.ynstr.2021.100304 [doi] PST - epublish SO - Neurobiol Stress. 2021 Feb 4;14:100304. doi: 10.1016/j.ynstr.2021.100304. eCollection 2021 May.